Coronavirus Notebook: UK To Start World’s First COVID-19 Challenge Study, Janssen Files Its Vaccine For EU Approval
Cuba is about to begin Phase III trials with one of its four homegrown coronavirus vaccines, Australia has provisionally approved the AstraZeneca/Oxford University product, and the EU has upped its orders from Pfizer/BioNTech and Moderna.
You may also be interested in...
Janssen-Cilag has asked for a WHO Emergency Use Listing for its vaccine candidate, while azelastine and carrageenan are both showing promise as potential treatments for COVID-19.
Coronavirus Notebook: UK OKs Moderna Vaccine & Use Of Tocilizumab/Sarilumab In Hospitalized Patients
The EMA explains how to get six doses from a vial of the Pfizer/BioNTech vaccine, while the UK seems isolated in its decision to give the second dose of the vaccine 12 weeks after the first.
Two new projects have begun, one on standardizing the assessment of immune responses in individuals vaccinated in clinical trials, the other to improve understanding of potential immunity in patients who have been infected with SARS-CoV-2.